Clinical Trials Browser

Phase 1/2 × Head and Neck Neoplasms × Radiotherapy, Intensity-Modulated × Clear all

NCT03024489 2024-03-15

Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma

Phase 1/2 Unknown

Head and Neck Neoplasms

NCT00660218 2021-11-08

A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck Cancer

Phase 1/2 Completed

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00851877 2020-08-21

Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Head and Neck Cancer

Phase 1/2 Completed

37 enrolled 9 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Tongue Neoplasms

NCT00573989 2019-01-03

Intensity-Modulated Radiation Therapy, Pemetrexed, and Erlotinib in Treating Patients With Recurrent or Second Primary Head and Neck Cancer

Phase 1/2 Terminated

27 enrolled 18 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03051906 2017-11-22

DUCRO-HN

Phase 1/2 Unknown

Carcinoma, Squamous Cell, Head and Neck Neoplasms

NCT00137475 2016-02-26

Using Intensity-Modulated Radiation Therapy to Permit Sparing of Parotid Gland Function

Phase 1/2 Completed

Head and Neck Neoplasms